Published in Virology on January 01, 1992
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol (1994) 3.39
Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells. J Virol (1999) 2.43
Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J Virol (2004) 2.17
Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol (2002) 2.05
Herpes simplex virus glycoprotein K promotes egress of virus particles. J Virol (1995) 2.04
Effects of truncation of the carboxy terminus of pseudorabies virus glycoprotein B on infectivity. J Virol (2000) 1.67
Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J Virol (1993) 1.63
Requirement of interaction of nectin-1alpha/HveC with afadin for efficient cell-cell spread of herpes simplex virus type 1. J Virol (2001) 1.46
Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J Virol (1995) 1.37
Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proc Natl Acad Sci U S A (1994) 1.33
The UL45 gene product is required for herpes simplex virus type 1 glycoprotein B-induced fusion. J Virol (1994) 1.33
HveA (herpesvirus entry mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J Virol (1998) 1.27
Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB. J Virol (1995) 1.21
Glycoprotein gB (gII) of pseudorabies virus can functionally substitute for glycoprotein gB in herpes simplex virus type 1. J Virol (1994) 1.14
Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J Virol (1996) 1.13
Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus. J Virol (1994) 1.03
Contribution of endocytic motifs in the cytoplasmic tail of herpes simplex virus type 1 glycoprotein B to virus replication and cell-cell fusion. J Virol (2007) 0.96
Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries. Proc Natl Acad Sci U S A (1995) 0.93
Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B. J Virol (2013) 0.92
Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells. Ann Clin Microbiol Antimicrob (2007) 0.92
Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus. J Virol (2010) 0.91
Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96. J Virol (2001) 0.89
Glycoprotein B of herpes simplex virus type 1 oligomerizes through the intermolecular interaction of a 28-amino-acid domain. J Virol (1996) 0.86
Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans. J Virol (2014) 0.86
The C terminus of the B5 receptor for herpes simplex virus contains a functional region important for infection. J Virol (2005) 0.85
HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread. PLoS One (2014) 0.85
Characterization of BoHV-5 field strains circulation and report of transient specific subtype of bovine herpesvirus 5 in Argentina. BMC Vet Res (2011) 0.84
Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. J Virol (2004) 0.83
Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity. Med Microbiol Immunol (2010) 0.83
Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles. J Virol (1998) 0.82
Murine cytomegalovirus interacts with major histocompatibility complex class I molecules to establish cellular infection. J Virol (1993) 0.81
Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies. J Virol (1996) 0.79
Glycoprotein B of herpes simplex virus 2 has more than one intracellular conformation and is altered by low pH. J Virol (2012) 0.76
Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants. J Virol (1978) 11.19
Regulation of herpesvirus macromolecular synthesis. V. Properties of alpha polypeptides made in HSV-1 and HSV-2 infected cells. Virology (1977) 8.24
Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun (1980) 5.03
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies. J Virol (1984) 4.37
Serological analysis of herpes simplex virus types 1 and 2 with monoclonal antibodies. Infect Immun (1982) 4.22
Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J Virol (1985) 3.67
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect Immun (1982) 3.40
Characterization of post-translational products of herpes simplex virus gene 35 proteins binding to the surfaces of full capsids but not empty capsids. J Virol (1984) 2.95
Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J Virol (1982) 2.71
Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. J Virol (1982) 2.62
Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology (1984) 2.56
Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol (1985) 2.54
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells. Proc Natl Acad Sci U S A (1981) 2.48
Mutations affecting conformation or sequence of neutralizing epitopes identified by reactivity of viable plaques segregate from syn and ts domains of HSV-1(F) gB gene. Virology (1984) 2.44
Variability in the structural polypeptides of herpes simplex virus 1 strains: potential application in molecular epidemiology. Infect Immun (1976) 2.35
Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1. Virology (1986) 2.29
The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection. J Virol (1997) 2.24
Herpes simplex virus envelopment and maturation studied by fracture label. J Virol (1992) 2.10
Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology (1993) 2.02
Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet (1995) 2.01
A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. J Virol Methods (1986) 1.98
Construction and properties of a cell line constitutively expressing the herpes simplex virus glycoprotein B dependent on functional alpha 4 protein synthesis. J Virol (1986) 1.89
Transactivation of the grp78 promoter by malfolded proteins, glycosylation block, and calcium ionophore is mediated through a proximal region containing a CCAAT motif which interacts with CTF/NF-I. Mol Cell Biol (1991) 1.89
Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol (2000) 1.82
Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology (1984) 1.76
Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera. Infect Immun (1982) 1.71
Detection of type-specific antibody to herpes simplex virus type 1 by radioimmunoassay with herpes simplex virus type 1 glycoprotein C purified with monoclonal antibody. Infect Immun (1983) 1.65
Mapping of functional and antigenic domains of the alpha 4 protein of herpes simplex virus 1. J Virol (1988) 1.63
Herpes simplex virus glycoprotein gA/B: evidence that the infected Vero cell products comap and arise by proteolysis. J Virol (1982) 1.62
A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene. J Virol (1987) 1.55
Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc Natl Acad Sci U S A (1985) 1.50
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis (1983) 1.47
Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis. J Virol (1987) 1.46
Expression of herpes simplex virus glycoprotein C from a DNA fragment inserted into the thymidine kinase gene of this virus. Proc Natl Acad Sci U S A (1982) 1.45
Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies. Virology (1994) 1.36
Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis (1988) 1.29
Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies. J Gen Virol (1992) 1.25
The fibrillins. Int J Biochem Cell Biol (1999) 1.22
Determination of herpes simplex virus type-specific antibodies by enzyme-linked immunosorbent assay. J Clin Microbiol (1983) 1.21
Mitochondrial portrait of the Cabo Verde archipelago: the Senegambian outpost of Atlantic slave trade. Ann Hum Genet (2002) 1.19
The role of community consultants in designing an HIV prevention intervention. AIDS Educ Prev (2001) 1.19
The mtDNA catalogue of all Portuguese autochthonous goat (Capra hircus) breeds: high diversity of female lineages at the western fringe of European distribution. Mol Ecol (2005) 1.16
Prevalence of lower genital tract infections in pregnancy. Sex Transm Dis (1988) 1.16
The fibrillin-Marfan syndrome connection. Bioessays (1993) 1.16
Human cytomegalovirus ICP22, the product of the HWLF1 reading frame, is an early nuclear protein that is released from cells. J Gen Virol (1988) 1.15
An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane. J Virol (1999) 1.15
Monoclonal antibodies for rapid diagnosis and typing of genital herpes infections during pregnancy. Am J Obstet Gynecol (1983) 1.14
Accessory human cytomegalovirus glycoprotein US9 in the unique short component of the viral genome promotes cell-to-cell transmission of virus in polarized epithelial cells. J Virol (1996) 1.13
Phylogeography of the human mitochondrial haplogroup L3e: a snapshot of African prehistory and Atlantic slave trade. Ann Hum Genet (2001) 1.12
Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Virology (1995) 1.11
In vivo left ventricular functional capacity is compromised in cMyBP-C null mice. Am J Physiol Heart Circ Physiol (2006) 1.10
Comparative study on O-linked oligosaccharides of glycoprotein D of herpes simplex virus types 1 and 2. J Gen Virol (1988) 1.10
Role of apical and basolateral membranes in replication of human cytomegalovirus in polarized retinal pigment epithelial cells. J Gen Virol (1996) 1.09
Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects. Br J Clin Pharmacol (1984) 1.08
Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. Immunity (1997) 1.08
Characterization of epitopes on native and denatured forms of herpes simplex virus glycoprotein B. Virology (1988) 1.08
Evaluation of lead exposure in Uruguayan children. Bull Environ Contam Toxicol (2005) 1.08
A mutation in the ectodomain of herpes simplex virus 1 glycoprotein B causes defective processing and retention in the endoplasmic reticulum. Virology (1991) 1.04
Antibody-resistant mutations in cross-reactive and type-specific epitopes of herpes simplex virus 1 glycoprotein B map in separate domains. Virology (1988) 1.03
Mutations in conformation-dependent domains of herpes simplex virus 1 glycoprotein B affect the antigenic properties, dimerization, and transport of the molecule. Virology (1991) 1.02
The fibroblast growth factor receptor is not required for herpes simplex virus type 1 infection. J Virol (1992) 1.02
Conformation-defective herpes simplex virus 1 glycoprotein B activates the promoter of the grp94 gene that codes for the 94-kD stress protein in the endoplasmic reticulum. DNA Cell Biol (1995) 1.01
Lead contamination in Uruguay. Rev Environ Contam Toxicol (1999) 1.00
The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. J Gen Virol (1992) 0.99
Humoral immune response to functional regions of human cytomegalovirus glycoprotein B. J Med Virol (1997) 0.99
Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J Gen Virol (1992) 0.99
Blood lead in Uruguayan children and possible sources of exposure. Environ Res (1997) 0.98
Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding. J Virol (1996) 0.98
A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein. J Gen Virol (1989) 0.96
Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections. Infect Immun (1983) 0.96
Teaching hand hygiene to medical students using a hands-on approach. J Hosp Infect (2010) 0.96
Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells. J Virol (1998) 0.95
Mitochondrial DNA haplotyping revealed the presence of mixed up benign and neoplastic tissue sections from two individuals on the same prostatic biopsy slide. J Clin Pathol (2005) 0.93
Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet (1993) 0.93
Novel truncating mutations in PKP1 and DSP cause similar skin phenotypes in two Brazilian families. Br J Dermatol (2008) 0.93
Antibody response to cytomegalovirus polypeptides captured by monoclonal antibodies on the solid phase in enzyme immunoassays. J Clin Microbiol (1985) 0.93
Processing of N-linked oligosaccharides from precursor- to mature-form herpes simplex virus type 1 glycoprotein gC. J Virol (1984) 0.93
Comparative study of blood lead levels in Uruguayan children (1994-2004). Biol Trace Elem Res (2007) 0.93
Effects of the herbicide atrazine in neotropical catfish (Rhamdia quelen). Ecotoxicol Environ Saf (2013) 0.92
Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B. J Clin Invest (1990) 0.92
Pattern of mtDNA variation in three populations from São Tomé e Príncipe. Ann Hum Genet (2004) 0.91
Cytotrophoblasts infected with a pathogenic human cytomegalovirus strain dysregulate cell-matrix and cell-cell adhesion molecules: a quantitative analysis. Placenta (2006) 0.91
Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus. J Infect Dis (1987) 0.90
A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy. Hum Mol Genet (1995) 0.90
Bidirectional pigment granule migration in isolated retinal pigment epithelial cells requires actin but not microtubules. Cell Motil Cytoskeleton (1997) 0.90
Effect of epididymis handling conditions on the quality of ram spermatozoa recovered post-mortem. Theriogenology (2003) 0.89
Marfan syndrome: new clues to genotype-phenotype correlations. Ann Med (1999) 0.88
Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. Genomics (1993) 0.88
Primary structure and developmental expression of Fbn-1, the mouse fibrillin gene. J Biol Chem (1995) 0.87
The use of intertypic recombinants for analysis of gene organization in herpes simplex virus. IARC Sci Publ (1978) 0.87
Oligosaccharide chains of herpes simplex virus type 2 glycoprotein gG.2. Arch Biochem Biophys (1985) 0.86
Mutations of extracellular matrix components in vascular disease. Ann Thorac Surg (1999) 0.86